Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Retrospective Data Collection Study in Patients With Macular Oedema Receiving OZURDEX®
Authors not listed
Allergan · 2014
Abstract
This study will use retrospective data to evaluate the safety and efficacy of OZURDEX® (dexamethasone intravitreal implant 0.7 mg) in the treatment of macular oedema due to retinal vein occlusion (RVO) in clinical practice. No intervention will be administered as part of this study.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-08 MST
Cite this
APA
Anonymous. (2014). Retrospective Data Collection Study in Patients With Macular Oedema Receiving OZURDEX®. <em>Allergan</em>. https://clinicaltrials.gov/study/NCT02181530
Vancouver
Anonymous. Retrospective Data Collection Study in Patients With Macular Oedema Receiving OZURDEX®. Allergan. 2014.
BibTeX
@misc{anon2014Retros,
title = {Retrospective Data Collection Study in Patients With Macular Oedema Receiving OZURDEX®},
author = {Anonymous},
journal = {Allergan},
year = {2014},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Allergan 2011
Open access · US-GOV
Study of Ozurdex® Treatment Practice in Patients With Macular Oedema Due to Retinal Vein Occlusion
Allergan 2004
Open access · US-GOV
A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion
Sanwa Kagaku Kenkyusho Co., Ltd.
Open access · US-GOV
A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Branch Retinal Vein Occlusion
Bayer 2021
Open access · US-GOV
Assessment of the Safety and Drug Utilization of Intravitreal Aflibercept Injection in Mexican Routine Clinical Practice for the Treatment of Wet Age Related Macular Degeneration (wAMD), Diabetic Macular Edema (DME), Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO), Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO) and Myopic Neovascularization (mCNV). A Post-authorization Safety Study (PASS).
Aerie Pharmaceuticals 2019
Open access · US-GOV
A Multicenter, Open-label, Safety and Proof-of-concept Study to Assess Safety, Tolerability and Efficacy of AR-1105 in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO)
Celgene 2016
Open access · US-GOV